AzTrials
AzTrials

Acute DiseaseI-DEPTNCT04571021

Implementation of the Individual Danish Emergency Process Triage

A study testing I-DEPT and DEPT in people with Acute Disease and Emergencies, run by Herlev Hospital at 8 sites in Denmark.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The purpose of the study is to implement and evaluate a novel triage algorithm for risk stratification of acutely admitted patients in the Emergency Department. Read more about this study

Who is it for?
Ages 17 to 110 years
Conditions the study is for
Acute Disease, Emergencies, Clinical Syndrome
What is being tested?
I-DEPT and DEPT
Could I receive a placebo?
No, everyone receives an active treatment
How many people
250,000 participants
Where
8 sitesDenmark
Study dates
1 Oct 2020to 1 May 2022
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 17 to 110 years
  • All sexes
  • No healthy volunteers
  • Child, Adult, Older adult

Who may be able to join

  • Admission to a participating Emergency Department in the study period
  • Full triage assesment in the index admission

Who cannot join

  • Age below 17 years
  • Death at arrival or before triage assesment

Trial locations and contacts

8 sites in 1 country.

8 sites in 1 country

Denmark8 sites
  • Bispebjerg and Frederiksberg hospital

    Copenhagen, 2200

  • Herlev and Gentofte hospital

    Herlev, Capital Region, 2730

  • Nordsjællands Hospital

    Hillerød, 3400

  • Holbæk hospital

    Holbæk, 4300

  • Hvidovre, Amager and Glostrup Hospital

    Hvidovre, 2650

  • Sjælland University hospital

    Køge, 4600

  • Nykøbing Falster Hospital

    Nykøbing Falster, 4800

  • Slagelse Hospital

    Slagelse, 4200

Other trials in Denmark

About this study

Official title: Implementation of the Individual Danish Emergency Process Triage (I-DEPT)

The purpose of the study is to implement and evaluate a novel triage algorithm for risk stratification of acutely admitted patients in the Emergency Department.

Read the detailed description

Triage algorithms are used worldwide to risk assess and prioritize patients in the Emergency Departments. The aim is to identify patient at risk of deterioration or death and/or with a imminent need of treatment. The triage algorithms are also developed to identify patients at low risk, who safely can be assigned to the waiting room.

Currently, several different triage algorithms are used, and they are mostly based on consensus and exper- opinion. Therefore evidence concerning triage is limited.

The investigators has developed a novel evidence-based triage algorithm with integrated individual clinical assesment. The vitals measured at admission assigns the patient to a triage category, and based upon the clinical appearance of the patients, the triage nurse can adjust the assigned triage category to better reflect the patient. The triage algorithm used in Denmark is "DEPT", this algorithm is based purely on vitals and cause of admission and can not be adjusted.

I-DEPT is designed as a cluster randomized stepped-wedge non-inferiority study. The Aim is to implement and compare I-DEPT to the existing triage algorithm. All Emergency Departments in the Capitol Region and the Region og Zealand in Denmark will implement I-DEPT one department at a time (8 centers). The first will start the implementation on october 1, 2020 and after two months the next center will implement I-DEPT. Every two months a new center will start. During 16 months all centers will have implemented I-DEPT the sequence of centers was determined by randomization. The first 30 days of implementation will be censored and not included in the final analyses. The study will conclude with a period of 30 days follow-up. Patients will only be included once.

Being tested
I-DEPT, DEPT
Keywords
triage, risk stratification, emergency department
Medical subject headings
Acute Disease, Emergencies

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • I-DEPTOther

    Implementation of the novel triage algorithm

  • DEPTOther

    Existing triage algorithm

Study groups in NCT04571021
Study groupRoleWhat they receive
I-DEPTExperimentalNovel triage. The triage nurse can adjust the triage category one level of urgency down or one or two levels up.
Receives: Other: I-DEPT
DEPTActive comparatorExisting triage algorithm
Receives: Other: DEPT

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. 30-day mortality

    All cause mortality within 30 days following triage in the index admission by non-inferiority

    Measured: 30 days

Secondary outcomes (7)
  1. 2-day mortality

    All cause mortality within 2 days following triage in the index admission

    Measured: 2 days

  2. Distribution of triage categories

    There are four categories in both triage algorithms used in this study: (green (least urgent), yellow, orange, and red (most urgent))

    Measured: 1 day

  3. Patients in the orange triage category

    Number of patients assigned to the orange category

    Measured: 1 day

  4. Doctor assessment

    Time from triage to arrival of a doctor

    Measured: 1 day

  5. Days in hospital

    The number of days admitted to a hospital within 30 days

    Measured: 30 days

  6. Time in the Emergency Department

    Time spent in the Emergency department from triage to either admission, transfer or discharge

    Measured: 30 days

  7. Patients left without being seen

    Number of patients leaving the Emergency Department without being assessed by a doctor

    Measured: 30 days

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted30 Sep 2020
  2. Study start1 Oct 2020
  3. Primary completion1 May 2022
  4. Study completion1 May 2022

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Prevention
Allocation
Randomised
Intervention model
Sequential
Model description
Stepped-Wedge cluster randomized design
Masking
None (open label)
Enrolment
250,000 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04571021
Sponsor's protocol ID
568
Acronym
I-DEPT
Status last verified
Mar 2023
First submitted
24 Sep 2020
Last updated
3 Apr 2023
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing I-DEPT and DEPT in people with Acute Disease and Emergencies, run by Herlev Hospital at 8 sites in Denmark.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 3 Apr 2023. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 8 sites in Denmark. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

30-day mortality (time frame: 30 days). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 3 Apr 2023.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in